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Introduction: Cancer metastasis to the thyroid is extremely rare. The most common sites that have been reported
to metastasize to the thyroid gland are breast and kidney. As to primary lung cancer metastasizing to the thyroid
gland, only a few cases have been described in the literature.
Case presentation: We report a case of a 37-year-old white Arabian woman who had never smoked tobacco products
for whom a malignant thyroid mass revealed a primary lung tumor. She had a surgical excision for both the thyroid and
the pulmonary tumors, and received adjuvant chemotherapy. At 1 year, she is still in remission.
Conclusions: Our case is rare as it describes a case where the thyroid lesion was the revealing sign of an unknown lung
carcinoma. Management of thyroid metastases should depend on the individual situation and surgical excision should
be proposed whenever a patient’s condition is favorable.
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The thyroid gland is a rare target for metastatic tumors,
despite its rich vascular supply [1]. According to autopsy
studies, the incidence of metastatic tumors to the thyroid
ranges from 3.9% to 24.2% [2, 3]. The reported clinical in-
cidence does not exceed 4% of all thyroid malignancies [4].
The breast and kidney are the most reported primary sites
to metastasize to the thyroid gland. Isolated lung meta-
static disease to the thyroid gland has been rarely reported
in the literature [4–15]. To the best of our knowledge,
only a few cases of metastatic lung adenocarcinoma
to the thyroid gland have been reported, describing
all together four cases of thyroid lesions revealing a
lung carcinoma. In our clinical case, the thyroid was
the site of an unusual metastasis revealing an under-
lying lung adenocarcinoma not initially suspected.Case presentation
A 37-year-old white Arabian woman who had never
smoked tobacco products presented a nodular goiter
during a routine follow up with her endocrinologist. An* Correspondence: Jihane.khalil@gmail.com
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article, unless otherwise stated.ultrasound examination of her neck showed a 2.4×3.2cm
solid hypoechoic nodule of her right thyroid lobe. Her
left thyroid lobe and the isthmus appeared to be normal.
Serum levels of free triiodothyronine, free thyroxine, and
thyrotropin were within normal ranges. She was screened
for multiple endocrine neoplasias with negative results.
She underwent ultrasonogram-guided fine-needle as-
piration cytology (FNAC) that showed a cellular aspirate
comprising predominantly atypical epithelial cells having
hyperchromatic eccentric nucleus and a moderate to
abundant amount of vacuolated cytoplasm with occa-
sional scattered thyroid follicular epithelial cell clusters
with absence of colloid.
Her chest X-ray and abdominal ultrasound were normal.
She underwent a total thyroidectomy with neck ex-
ploration. The microscopic aspect of the nodule was
consistent with a well-differentiated carcinoma. Immu-
nohistochemistry demonstrated that these tumor cells
were positive for both cytokeratin 7 (CK7) and thyroid
transcription factor-1 (TTF-1) and were negative for
both CK20 and thyroglobulin, which concords with
metastatic disease from lung origin (Figs. 1 and 2).
A computed tomography (CT) scan of her chest along
with an upper abdomen CT was then performed, and re-
vealed a 4cm mass within the right upper lobe of heris distributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
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Fig. 1 High power view demonstrating positive immunostaining for
thyroid transcription factor-1 (G ×40)
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node and adrenal metastases.
Given these results, our case was presented during a
weekly board meeting, and the decision of a surgical ex-
cision of the pulmonary mass was made. Three weeks
later, our patient underwent a segmentectomy with
lymph node dissection. According to the pathologic
findings, the tumor was staged as IB (pT2a,N0,M0). She
was referred to our medical oncology department for ad-
juvant therapy, where she received six cycles of an adju-
vant platinum and vinorelbine-based regimen.
After 1 year of follow up, she continues to be in
remission.
Discussion
Lung cancer is the leading cause of cancer death world-
wide, with an estimated 1.4 million deaths each year [16].
Lung cancer also has a high prevalence of metastases; itFig. 2 High power view demonstrating negative immunostaining
for thyroglobulin (G ×40)commonly metastasizes to the brain, bones, adrenal
glands, contralateral lung, and liver. Despite the rich
vascular supply of the thyroid gland, coming right after
the adrenals [17], it has been rarely reported as a site of
metastases especially to lung carcinoma.
The incidence of thyroid metastases in patients with a
known malignancy varied in large autopsy series from 1.9
to 24% [18–21]. In these series, cancers of the breast, lung
and malignant melanoma were the most frequent malig-
nancies to metastasize to the thyroid, with the metastases
being clinically occult. The site of origin of clinically sig-
nificant thyroid metastases appears to be different. In fact,
many clinical series have shown that renal cell carcinoma
is the most common primary tumor causing symptomatic
thyroid metastases, followed by breast and lung [22–27].
It is often difficult to distinguish between metastasis
and a second primary cancer. Typically, the interval be-
tween the diagnosis of the primary tumor and the detec-
tion of thyroid metastasis is from 1 month to 26 years
[4, 17]. In our case, a thyroid lesion was the revealing
sign of lung adenocarcinoma; only a handful of similar
cases have been described in the literature [7, 8].
In our case, the diagnosis of the thyroid metastasis
was based on FNAC, which was further substantiated by
the biopsy and immunohistochemical examination
(IHC). Fine-needle aspiration (FNA) with ultrasound
guidance is a rapid, minimally invasive, and inexpensive
technique with a high predictive negative value [28]. In
the metastatic setting, there is abundant cellularity and
the cells may be typical of the original site, especially
when specific immunohistochemical stains are per-
formed. Negative staining with anti-thyroglobulin and
anti-calcitonin antibodies would favor a metastatic
tumor. However, FNA may not be contributory to the
diagnosis as it may contain insufficient tumor cells to
make the cell block used for immunostains. Diagnostic
re-evaluation of the primary tumor and search for other
metastatic sites is necessary.
Metastases to the thyroid gland were associated with a
poor prognosis in multiple series [1]. However, radical
treatment of an isolated metastasis to the thyroid gland
was shown to be curative [4, 21]. In fact, an improvement
in the survival rates (34 months of median survival versus
25 months in the not operated group) was reported when
radical treatment was employed [5]. Another series, re-
ported a disease-free survival of 84 months in the patients
where lobectomy was performed [10]. Thus, an aggressive
surgical approach has been recommended by many au-
thors [8, 29–32], even though surgical treatment is still
controversial. Papi et al. [27], in their report suggested
that the good indication of thyroidectomy for multinodu-
lar toxic goiter (MTG) is limited to patients whose metas-
tases are limited only to the thyroid from the viewpoint of
preventing further dissemination of the primary tumor.
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scribed as a good therapeutic approach for palliation of
symptoms due to thyroid metastases [8]. In our case, the pa-
tient had a radical excision of both the primary tumor and
the metastasis, and remains well after a 1-year follow up.
Given the available data, we can conclude that the sur-
vival of patients with thyroid metastases is variable and
depends on the primary cancer, the treatment approach
and the presence of other distant metastases. Primary
renal cancer has been reported to be associated with bet-
ter survival rates when compared to extrarenal locations
[19]. Prolonged survival of more than 5 years was ob-
served in the cases where surgical excision was performed
[4, 7, 17, 28]. Finally, patients with multiple metastases
present the worse survival rates (5% at 5 years) [33].
Conclusions
Metastases to the thyroid gland are not as uncommon as
previously thought; however, our case is unusual as it de-
scribes a case where the thyroid lesion was the revealing
sign of an unknown lung carcinoma. Metastases to the
thyroid gland have been associated with poor outcomes,
although surgical treatment enhances the chances of bet-
ter overall survival and disease-specific survival. There-
fore, management of thyroid metastases should depend
on the individual situation and surgical excision should be
proposed whenever a patients’ condition is favorable.
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